Introduction
Myocardial infarction (MI), commonly referred to as a heart attack, is a leading cause of death worldwide with a high associated health care cost for survivors. After an MI the cardiac tissue damaged due to lack of oxygen causes a wound healing response that replaces the damaged cardiac tissue with non-contractile scar tissue. This results in reduced cardiac function, leading to reduced quality of life and further complications for the patient. Cardiac stem cell therapy is an approach that aims to replace and regenerate new functional cardiac tissue, through the introduction of targeted stem cells that will differentiate into cardiomyocytes around the affected areas within the heart. Stem cell therapy has advantages over current therapies, such as by-pass graft surgery or complete organ transplantation, as it does not require donor organs or complicated open heart surgeries. However, current clinical trials of cardiac stem cell therapy have been unsuccessful; high stem cell mortality within the first few days after injection and low retention are major contributors to this lack of clinical efficacy. [1] The cardiac environment is also quite difficult for injected cells to survive due to immune responses, inadequate vascularization, fibrosis and inadequate access to nutrients. [2, 3] For these reasons, the direct injection of stem cells into cardiac tissue is not a beneficial approach; instead, delivering the stem cells on an implantable platform, or cardiac patch, would provide a more stable environment and allow the stem cells time to develop into effective tissue [4] . Grafting stem cells onto bio-engineered tissue scaffolds can address the majority of the issues that currently limit the efficacy of cardiac stem cell therapy. The use of electrospun fibres for the support of cardiac cells has an advantage due to similarity to extracellular matrix morphology, as well as the ability to tailor fibres in dimension, composition, and functionality. Different types of fibre materials have been used for stem cell graft materials, such as nano-and micro-sized fibres with different polymer compositions [5] and bio-functionalised fibres [6] . The 3-dimensional morphology provided by the fibres makes for a good basis for a cardiac patch. The introduction of an electroactive material to the fibres provides another aspect to the influence and control of the stem cells on the fibres [7] . Electroactive polymers (EAP), such as polypyrrole (PPy), are conductive and when reduced/oxidized they will mechanically actuate [8] . This provides the possibility to stimulate stem cells both electrically and mechanically while growing on the cardiac patch. Electrical and mechanical stimuli have demonstrated in the past to stimulate stem cells and to influence differentiation into cardiac type cells [9] [10] [11] . EAP coated fibres have been demonstrated to work as support for many types of cells, including neural, myogenic, and cardiac cells [12] [13] [14] [15] . Following on from this foundation, we will produce EAP coated fibres using PPy to investigate the response from primary and stem cells. Our previous work has demonstrated the efficacy of using PPy materials prepared with dodecylbenzenesulfonate (DBS), as the polymer showed to be biocompatible with endothelial progenitor cells and cardiac progenitor cells (CPCs) [16] . CPCs are resident cardiac stem cells with the ability to generate cardiomyocytes, smooth muscle, and endothelial cells and have the potential to generate new functional cardiac tissue [17, 18] . Hence, we begin this study observing PPy(DBS) coated fibre materials and the response from CPCs to observe how primary cells respond. We will then move onto iPS cells, which are generally more sensitive and difficult to culture successfully [19] but offer true pluripotency compared to the CPCs. Comparing the behavior of the two cell types will help elucidate the suitability of EAP coated fibres for cardiac tissue engineering.
Materials & methods

Scaffold fabrication
The electroactive scaffolds are prepared in a step-by-step process as shown in the scheme in Figure 1 . 50:50 poly(lacticco-glycolic acid) was prepared as a 17.5% wt/wt solution in chloroform. The PLGA solution was electrospun at a voltage of 20 kV with a flow rate of 0.5 mL/hour with a throw distance of 120 mm (Fig.1A) . The electrospun PLGA fibres were then collected and dried over night to evaporate any remaining solvent. The fibres were then coated with a solution of 5% wt/wt iron (III) chloride in methanol using a spincoater (WS-400B-6NPP/LITE, Laurell Tech. Corp., USA) with an initial step of 1000 RPM for 120 seconds, followed by 2500 RPM for 30 seconds (Fig. 1B) . The FeCl 3 coated fibres were then dried over night to evaporate any remaining solvent. The fibres are then exposed to pyrrole (Py) vapour in a sealed vessel at 50°C for 60 seconds (Fig. 1C ). An aqueous monomer solution of 0.1M Py and 0.1 M dodecylbenzenesulfonic acid (TCI) was prepared. For electropolymerisation the aqueous pyrrole solutions were prepared with 0.1 M concentration of dopant (DBSA) and 0.1 M pyrrole. The VPP coated mesh was then placed into the aqueous pyrrole/dopant solution in a 3 point electrochemical cell (Fig. 1D) The counter electrode was a gold coated silicon wafer, and the reference a Ag/AgCl reference electrode. A constant potential of 0.67 V was applied to the electrochemical cell for 600 or 1800 sec. The ECP coated mesh was then lightly rinsed three times with DI water, dried gently with N2 gas, and stored in a Petri dish. All chemicals are supplied from Sigma Aldrich unless indicated otherwise. (Fig.  ive (Fig. 3A) . ECP coating; a LIVE/DEAD® bility, and cel numbers were by retroviral IPS cells were Cell Medium , STEMCELL ubating with 1 en cultured in acids, 0.1 mM nitiate cardiac e plate with a coating of PPy the secondary g. 2B,C). The 00 nm. Due to the 3D detailed analy (Fig. 4A) spread on the fibres after 10 days in culture without severe apoptosis, indicating that they are also compatibile with th e EAP fibres. This study leads the way to introducing external stimulus via the electroactive coating in the future, to provide further control and direction over stem cell fate for cardiac tissue regeneration.
